Nuclear transport surveillance of p53 by nuclear pores in glioblastoma

Cell Rep. 2023 Aug 29;42(8):112882. doi: 10.1016/j.celrep.2023.112882. Epub 2023 Aug 7.

Abstract

Nuclear pore complexes (NPCs) are the central apparatus of nucleocytoplasmic transport. Disease-specific alterations of NPCs contribute to the pathogenesis of many cancers; however, the roles of NPCs in glioblastoma (GBM) are unknown. In this study, we report genomic amplification of NUP107, a component of NPCs, in GBM and show that NUP107 is overexpressed simultaneously with MDM2, a critical E3 ligase that mediates p53 degradation. Depletion of NUP107 inhibits the growth of GBM cell lines through p53 protein stabilization. Mechanistically, NPCs establish a p53 degradation platform via an export pathway coupled with 26S proteasome tethering. NUP107 is the keystone for NPC assembly; the loss of NUP107 affects the integrity of the NPC structure, and thus the proportion of 26S proteasome in the vicinity of nuclear pores significantly decreases. Together, our findings establish roles of NPCs in transport surveillance and provide insights into p53 inactivation in GBM.

Keywords: 26S proteasome; CP: Cancer; CP: Molecular biology; GBM; MDM2; NUP107; p53.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Active Transport, Cell Nucleus
  • Glioblastoma* / metabolism
  • Humans
  • Nuclear Pore Complex Proteins / metabolism
  • Nuclear Pore* / metabolism
  • Tumor Suppressor Protein p53 / metabolism

Substances

  • Nuclear Pore Complex Proteins
  • Tumor Suppressor Protein p53